Hanmi Pharm Co Ltd
128940
Company Profile
Business description
Hanmi Pharm Co Ltd is a Korea-based company, engaged in manufacturing and marketing of medicines, medical supplies and raw materials for medicines. The company makes strenuous and enthusiastic efforts to develop treatments for diabetes, obesity, cancer, autoimmune and rare disease to keep everyone's health and improve their quality of life. The group distributes its products within Korean market and to overseas markets.
Contact
45 Bangi-dong
Songpa
SeoulGyeonggi138-724
KORT: +82 313505600
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
2,344
Stocks News & Analysis
stocks
Our view of the supermarkets after earnings
Are the shares of two of Australia’s best known brands attractive?
stocks
Has uncertainty created an opportunity in Jack Daniel's owner?
Investors seem to be questioning long-term demand trends in alcohol. This may have sent the valuation of Wide Moat spirits company Brown Forman down too far.
stocks
Nvidia earnings: Despite DeepSeek news, no signs of waning near-term chip demand
We’re maintaining our fair value estimate after another strong quarter.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,403.90 | 102.20 | -1.20% |
| CAC 40 | 8,111.63 | 9.11 | 0.11% |
| DAX 40 | 22,551.43 | 0.54 | 0.00% |
| Dow JONES (US) | 43,396.99 | 157.49 | 0.36% |
| FTSE 100 | 8,809.74 | 53.53 | 0.61% |
| HKSE | 22,941.32 | 776.97 | -3.28% |
| NASDAQ | 18,597.22 | 52.80 | 0.28% |
| Nikkei 225 | 37,155.50 | 1,100.67 | -2.88% |
| NZX 50 Index | 12,601.42 | 60.55 | 0.48% |
| S&P 500 | 5,883.12 | 21.55 | 0.37% |
| S&P/ASX 200 | 8,172.40 | 95.80 | -1.16% |
| SSE Composite Index | 3,320.90 | 67.17 | -1.98% |